STING1 and neoplasm: Indeed, anti-tumor immunity in MMRd cancers also depends on the magnitude of cGAS/STING activation and subsequent expression of CCL5 and CXCL10 in the tumor microenvironment (TME), which influences CD8+ T and NK cell infiltration (96, 102) (Figure 1E).